Bracco Receives Health Canada Approval for VUEWAY(R) injection (gadopiclenol), Advancing Lower-Dose MRI Contrast Imaging

Approval marks a major milestone in reducing gadolinium exposure while maintaining diagnostic performance, aligning with clinical guidance to use the lowest effective dose MONTREAL, April 17, 2026 ...
Verywell Health on MSN

How MRI with contrast works

Medically reviewed by Rony Kampalath, MD Key Takeaways An MRI with contrast uses a special dye to make blood vessels, organs, and tissues stand out more clearly.The dye used in MRI with contrast ...
Daijiworld

Study finds contrast mammography matches MRI in tumour assessment

Contrast-enhanced mammography (CEM) demonstrates performance comparable to MRI in assessing tumour size and detecting additional malignant lesions, with closer agreement to histopathology in ...
Business Wire

Bayer’s investigational MRI contrast agent gadoquatrane meets primary and main secondary endpoints in pivotal Phase III studies

BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...
European Medical Journal

CEM Matches MRI in Breast Cancer Imaging Performance

CEM breast cancer imaging shows strong agreement with MRI and histopathology for tumour size and disease extent. Learn more.
Case Western Reserve University

MRI contrast agent locates and distinguishes aggressive from slow-growing breast cancer

A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between ...
Medscape

Contrast-Enhanced Breast MRI Shows Promise in Identifying High-Risk Lesions That May Not Need Surgery

Contrast-enhanced MRI demonstrated a sensitivity of 91.3% and a specificity of 68.8% in assessing high-risk breast lesions, with the potential to help patients avoid unnecessary surgery, according to ...

Bracco Receives Health Canada Approval for VUEWAY® injection (gadopiclenol), Advancing Lower-Dose MRI Contrast Imaging

Bracco Imaging, a global leader in diagnostic imaging, today announced that Health Canada approved VUEWAY® injection (gadopiclenol), a macrocyclic gadolinium-based contrast agent (GBCA), for use in ...